Department of Medical Oncology

Manchester M20 4BX

0 studies enrolling now · 3 studies all time

What they study most

Advanced Breast Cancer, Advanced Gastric Cancer, Advanced/Metastatic Non-Small Cell Lung Cancer, Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma, Gastrointestinal Stromal Tumor, Hepatocellular Carcinoma, Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, Metastatic Renal Cell Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer

Studies at this site

• A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. — Completed
• OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. — Completed
• Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer — Completed